S100A9-targeting quinoline compounds (Active Biotech)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameS100A9-targeting quinoline compounds (Active Biotech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionS100 calcium binding protein A9 inhibitors
TargetsS100 calcium binding protein A9
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActive Biotech Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActive Biotech Ab
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A